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Abstract 
Aims˖To observe the apoptosis-related genes expression in the difference groups and the action of Valeriana 
jatamansi Jones. Methods˖EPM was used to make the anxiety model of rat. The gene expression difference chart of 
apoptosis-related gene in normal rats, anxiety model rats and rats treated by the extract of Valeriana jatamansi Jones 
were examined by using the gene chip technology. Results˖Compared with normal groupˈthe expression of Elk-1, 
Ets-1, Apaf-1, Bax and Bcl-2 were up-regulated in the model group. But the abnormal gene expression were adjusted 
in the other groups. Conclusion: The Valeriana jatamansi Jones can play a important role in regulating the abnormal 
apoptosis-related gene expression in the anxiety model of rat. 
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1.Introduction 
Anxiety is one of the important neuroses, and a frequently-occurring disease[1]. Modern studies show 
that anxiety relates to hereditary factor in part at the least. In the unhealthy environmental influence or 
stress state, people who possessed tendency of anxiety show easily pathological anxiety[2]. Under the 
anxiety state, various kinds of neurotransmitters system[3], neuropeptide system[4] and neuroendocrine 
system[5]of brain have interactions in different regions and level of brain.  
Apoptosis is an basic, genetically regulated and finely tuned process of cell elimination essential for 
embryogenesis, development and tissue homeostasis of multicellular organisms[6]. It takes part in the 
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normal development and functions of organisms in humans[7]. Dysregulation or impairment of apoptosis 
has deleterious consequences. In humans, pathological conditions such as neurodegenerative and 
autoimmune diseases, cancer or AIDS have defective apoptosis in the pathogenetic route[8]. Recent 
researches show there some connection between the altered expression of apoptosis-related genes and the 
development of anxiety[9]. 
Valeriana jatamansi Jones is the dry roots and rhizomes of Valeriana jatamansi Jones plant 
(Valerianaceae), which is described to treat the abdominal distention and pain, diarrhea and dysentery, 
rheumatism and insomnia[10]. Modern studies showed that it has sedative hypnotic, improving 
coordination and antitumor effect[11-13]. Previous studies have demonstrated Valeriana jatamansi Jones 
has the distinct effect of antianxiety. The mechanisms are related with regulating the content of 
neurotransmitter in the brain and regulating HPA axis function [14,15]. However, the role on apoptosis-
related genes during the anxiety state remains poorly understood. 
In the present study, the apoptosis-related genes expression difference chart in normal rats, anxiety 
model rats and rats treated by the extract of Valeriana jatamansi Jones were examined by using the gene 
chip technology. The aims of this study were to observe the apoptosis-related genes expression in the 
difference groups and the action of Valeriana jatamansi Jones. 
2.Materials and Methods  
2.1.Materials 
Animals˖A total of 72 healthy, male, Sprague Dawley rats, aged 2 months and weighing (250f10) g, 
were fed 1 week prior to experimentation. 
Drugs˖Valeriana jatamansi Jones˖Valeriana jatamansi Jones herbs were purchased from Lotus 
Pond Market for Chinese Herbal Medicine in Chengdu and consisted of iridoids and flavonoid 
components. Extraction was performed twice, using six times the volume of 95% ethanol, 30°C 
ultrasound, for 30 minutes each. Extracts were prepared with normal saline into low, medium, and high 
doses (0.015, 0.030, and 0.045 g/mL, respectively) following ethanol removal by rotary steam. Estazolam 
was purchased from Shanghai Jiufu Pharmaceutical, China. After grinding with a mortar, 0.075 mg/mL 
suspension was prepared with addition of normal saline.All drugs were stored in the dark at 4 °C and 
were shaken prior to use. 
Main reagents and instruments were as follows˖Trizol reagent˖ Invitrogen life technologies˗
RNALater˖Sigma˗Biotin-labeled UTP˖Roche˗('7$1D˖Chengdu Chemical Reagent Factory˗
Elevated plus-maze˖Chengdu TME Technology˗Microplate reader˖Bio-Rad Laboratories˗Gene 
chip, ArrayGrade cRNA purification kit, GEAhyb hybridization solution, GEArray  Analyzer˖Super 
Array Bioscience. 
2.2.Methods 
Grouping and interventions˖A total of 72 Sprague Dawley rats were randomly assigned to six 
groups˖normal, model, estazolam, and high, medium, and low Valeriana jatamansi Jones, with 12 rats 
in each group. Valeriana jatamansi Jones groups were intragastrically injected with 0.3, 0.6, and 0.9 
g/kg/day of Valeriana jatamansi Jones extract, the estazolam group with 1.5 mg/kg/day (5 mL estazolam), 
and model and normal group with 5 mL physiological saline. Administration was performed for 7 
successive days. 
Elevated plus-maze test[16]˖On day 7, the elevated plus-maze test was performed at 1.5 hours 
following the last administration of Valeriana jatamansi Jones extract, and 0.5 hours following estazolam 
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or saline . Each group was tested in a crossing way. The normal group was not tested. Each rat was tested 
for 5 minutes. The blankets were cleaned after each rat was tested. 
Preparation of tissue specimens˖Subsequent to the completion of elevated plus-maze test, the rats 
were immediately decapitated. The calvaria and cranial meninges were quickly removed and placed in ice. 
Brain tissues were removed, rinsed with phosphate buffered saline, cut to slices < 0.5 cm thickness, and 
placed into tubes with five times the volume RNALater (Sigma). Sections were incubated at 4 °C 
overnight and stored at –20 °C for gene microarray. 
Brain tissue neurotrophic factors gene expression were measured by microarray˖Trizol reagent was 
added to the brain tissue samples to homogenize the extracted RNA. cDNA synthesis was performed 
through reverse transcription with RNA amplification buffer, biotin-labeled UTP and amplified enzyme 
mixture to synthesize biotin-labeled cRNA probe. The resulting probe was purified using SuperArray 
ArrayGrade cRNA/cRNA purification kit. The purified cRNA probe was hybridized to the chip with 
GEAhyb hybridization solution. Streptavidin-coupled alkaline phosphatase and chemiluminescent 
substrate CDP-Star were added. Following X-ray film exposure, the film image was scanned using a 
scanner. Chip data were calculated with background grey value deleted, and measurements were 
compared with GEArray Analyzer software. The background minimal value was subtracted and then 
corrected according to a housekeeping gene. Resulting data were used for relative abundance analysis of 
gene transcription between samples. 
3.Results 
3.1.Identification of differentially expressed genes by microarray 
Differential gene expression was determined according to the ratio of fluorescence in the detected 
genes between the model group and other groups. There was no significant difference between two 
groups at a ratio range of 0.5 to 2, with high levels in the model group at a ratio > 2, and low levels in the 
model group at a ratio < 0.5. 
In a total genes analyzed, 32transcripts, including 30 up-regulated and 2 down-regulated transcripts 
were altered among difference groups. The function of these genes include apoptosis, neurotrophins and 
receptors, immune response. 
3.2.Differential apoptosis-related gene expression among difference groups 
A total of 5 apoptosis-related genes were differentially expressed in each group, as detected by 
microarray (Figure1. ). 
These gene included Elk-1(NM_007922), Ets-1(NM_011808), Apaf-1(NM_009684), 
Bax( NM_007527)  and  Bcl-2(NM_009741). 
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Figure1. The gene expression difference chart of difference groups 
3.3.Microarray analysis data of differentially expressed apoptosis-related genes 
We searched for the database of these genes in the National Center for Biotechnology Information 
(Table1). 
Table1. Function analysis of the differentially expressed apoptosis-related genes 
GenebankID Definition Symbol 
NM_007922 M.musculus mRNA for elk1 protein               Elk-1 
NM_011808 E26 avian leukemia oncogene 1, 5' domain    Ets-1 
NM_009684 Apoptotic protease activating factor 1            Apaf-1 
NM_007527 Bcl2-associatedXprotein                                 Bax 
NM_009741   B-cell leukemia/lymphoma2                         Bcl-2 
4. Discussion 
The elevated plus-maze model is a non-conditioned reflex model, which is typically recognized for 
antianxiety animal models[17–20]. It is based on spontaneous behavior, with no special training required 
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for animals, and uses comparative behavior of animals between exploration of a novel environment and 
fear of being in the open arm. The percentage of entering the open arm (OE%) and staying in the open 
arm (OT%) served as experimental indices for anxiety. OT% and OE% were significantly reduced in the 
anxiety animals, and antianxiety drugs increased both values[21]. The elevated plus maze is simple, fast, 
stable, and sensitive. Experimental results demonstrated that the percentages were significantly reduced in 
anxiety model rats following open arm testing compared with the drug groups. Both drug groups and 
model group exhibited increased percentages[14]. The model was successfully established and Valeriana 
jatamansi Jones extract exhibited an anxiolytic effect. 
In this study, 5 apoptosis-related genes including Elk-1, Ets-1, Apaf-1, Bax and Bcl-2 were 
differentially expressed in each group.  
ElK1 is a member of the ternary complex factor (TCF) subfamily of ETS-domain transcription 
factors[22]. It has been shown to be positively regulated by activation of the MAPK pathway, and 
transcribes the growth factors that induce the cell differentiation and multiplication[23]. Ets-1 is a 
member of the Ets protein family of transcription factors, regulates the expression of some kinds of 
proteins through its interaction with specific consensus sequences upstream of target genes. Ets family 
modulate the expression of a variety of genes involved in diverse cellular processes, including cell 
proliferation, differentiation, apoptosis, and cell-cell/cell-matrix interactions[24]. The over expression of 
Ets has been associated with a multitude of different cancers, specifically with regards to tumour 
progression and invasion [25,26]. 
Apoptosis is a form of programmed cell death required for proper embryonic development and tissue 
homeostasis. In the intrinsic pathway of apoptosis, death-inducing signals converge upon the 
mitochondria, causing release of cytochrome c. Cytosolic cytochrome c binds to Apaf-1 (apoptotic 
protease-activating factor 1), that acts as an adaptor in multiprotein complex (named the apoptosome) to 
mediate the activation of caspase-9. The activation of caspase-9 leads to the subsequent cleavage and 
activation of downstream executioner caspases, which in turn cleave specific protein substrates, leading to 
the final destruction of cells[27-29]. 
Bcl-2 (B-cell lymphoma 2) is the founding member of the Bcl-2 family of apoptosis regulator proteins 
encoded by the BCL2 gene. Bcl-2 family proteins play an important role in irradiation-induced apoptosis 
[30,31]. The Bcl-2 family of proteins consists of 25 pro- and anti-apoptotic members, which interact to 
maintain a balance between newly forming cells and old dying cells. Bcl-2 and Bax, the two main 
members of the Bcl-2 protein family, act as anti-apoptotic and pro-apoptotic factors respectively [32,33]. 
Bcl-2 can prevent the release of cytochrome c and apoptosis inducing factor from mitochondria, 
forthermore inhibit Bax conformational change and insertion into outer mitochondrial membrane. 
The results of gene chip examination indicate˖ Compared with normal group, the expression of Elk-1, 
Ets-1, Apaf-1, Bax and Bcl-2 were up-regulated in the model group. The apoptosis-related genes 
expression were indiscriminate under the anxiety state . But the abnormal gene expression were adjusted 
in the rats treated by the extract of Valeriana jatamansi Jones. It is concluded that the antianxietic 
mechanism of Valeriana jatamansi Jones is closely connected with the adjustment to the gene expression 
profiling of the apoptosis-related genes. 
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